Advertisement
Singapore markets closed

  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     

  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     

  • Bitcoin USD

    64,239.26
    +664.57 (+1.05%)
     

  • CMC Crypto 200

    1,384.30
    +71.67 (+5.46%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • Dow

    37,986.40
    +211.02 (+0.56%)
     

  • Nasdaq

    15,282.01
    -319.49 (-2.05%)
     

  • Gold

    2,406.70
    +8.70 (+0.36%)
     

  • Crude Oil

    83.24
    +0.51 (+0.62%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     

  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     

  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

United States Insulin Syringes Market Report 2021: Market is Set to Surpass $1 Billion by 2027

Research and Markets
·2-min read

Dublin, Oct. 21, 2021 (GLOBE NEWSWIRE) -- The "United States Insulin Syringes Market and Forecast 2021-2027" report has been added to ResearchAndMarkets.com's offering.

The United States Insulin Syringes Market is set to surpass US$ 1 Billion by 2027.

This new market report presents a comprehensive study of the entire U.S. insulin syringes market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the U.S. insulin syringes market.

The report also provides up-to-date market size data for the historical period 2019 - 2020 and an illustrative forecast to 2027 covering key market aspects like market value, volume, and pricing analysis for insulin syringes.

ADVERTISEMENT

Key Questions Addressed by the Report

  • What is the current size of the overall insulin syringes market in the United States?

  • How much will this market be worth from 2021 to 2027?

  • How big is the United States insulin syringes market?

  • How much do insulin syringes cost?

  • What are the key marketed insulin syringes devices available in the United States?

  • What are the major drivers of the United States insulin syringes market?

  • What are the major challenges of the United States insulin syringes market?

  • What is the reimbursement pattern in the United States insulin syringes market?

  • What is the regulatory framework in the United States insulin syringes market?

  • Which companies make insulin syringes?

  • Who are the top market players? What are their happenings, current developments, and scenarios?

The Leading Companies for the United States Insulin Syringes Market are Listed Below:

  • Arkray, Inc

  • UltiMed, Inc

  • Allison Medical, Inc

  • Cardinal Health, Inc

  • Abbott Diabetes Care

  • Smiths Medical, Inc.

  • Eli Lilly and Company

  • Trividia Health, Inc

  • MHC Medical Products, LLC

  • Home Aide Diagnostics, Inc

  • Retractable Technologies, Inc.

  • Prodigy Diabetes Care, LLC

  • AdvaCare Pharma USA, LLC

  • Becton, Dickinson, and Company (BD)

  • Advocate Meters (Pharma Supply, Inc.)

Key Topics Covered:

1. Executive Summary

2. United States Diabetes Population and Forecast, 2019 - 2027

3. United States Insulin Users Volume and Forecast, 2019 - 2027

4. United States Insulin Syringe Users Volume Assessment and Forecast, 2019 - 2027

5. United States Insulin Syringe Market Analysis, Insights and Forecast, 2019 - 2027

6. Key Market Growth Drivers and Challenges of the United States Insulin Syringe Market

7. Reimbursement Environment of the United States Insulin Syringe Market

8. Regulatory Framework of the United States Insulin Syringe Market

9. Key Companies Profiles (Overview and Key Marketed Products)

For more information about this report visit https://www.researchandmarkets.com/r/wq4j1g

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900